Diagnosis of human sleeping sickness: Sense and sensitivity

Trends in Parasitology

Volumn 27, Issue 9, 2011, Pages 394-402

  Wastling, Sally L ^a   Welburn, Susan C ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN TRYPANOSOMIASIS; CEREBROSPINAL FLUID; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE AMPLIFICATION; GOLD STANDARD; HUMAN IMMUNODEFICIENCY VIRUS; LAMPREY; LEUKOCYTE COUNT; LIGHT EMITTING DIODE; MOLECULAR DIAGNOSIS; NONHUMAN; NUCLEIC ACID SEQUENCE BASED AMPLIFICATION; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REVIEW; SENSITIVITY ANALYSIS; SEROLOGY;

AFRICA; ANTIGENS, PROTOZOAN; DIAGNOSTIC ERRORS; GENES, PROTOZOAN; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PARASITE LOAD; PREVALENCE; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; TRYPANOSOMA BRUCEI GAMBIENSE; TRYPANOSOMIASIS, AFRICAN;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 80051797177     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2011.04.005     Document Type: Review

References (99)

1. de Raadt P. The history of sleeping sickness. Fourth International Course on African Trypanosomiasis 2005, World Health Organization. http://www.who.int/trypanosomiasis_african/country/history/en/index.html.
2. Maudlin I. African trypanosomiasis. Ann. Trop. Med. Parasitol. 2006, 100:679-701.
3. Forde R.M. The discovery of the human Trypanosoma. Brit. Med. J. 1902, 2:1741.
4. Dutton, J.E. (1902) Thompson Yates Laboratory Report 4.
5. Stephens J.W.W., Fantham H.B. On the peculiar morphology of a trypanosome from a case of sleeping sickness and the possibility of its being a new species (T. rhodesiense). Proc. R. Soc. Lond. B 1910, 83:28-33.
6. Büscher P., Lejon V. Diagnosis of human African trypanosomiases. The Trypanosomiases 2004, 203-218. CABI Publishing. I. Maudlin (Ed.).
7. Checchi F., et al. Estimates of the duration of the early and late stage of gambiense sleeping sickness. BMC Infect. Dis. 2008, 8:16.
8. Welburn S., et al. Sleeping sickness: a tale of two diseases. Trends Parasitol. 2001, 17:19-24.
9. Odiit M., et al. Duration of symptoms and case fatality of sleeping sickness caused by Trypanosoma brucei rhodesiense in Tororo, Uganda. E. Afr. Med. J. 1997, 74:792-795.
10. Chappuis F., et al. Options for field diagnosis of human African trypanosomiasis. Clin. Microbiol. Rev. 2005, 18:133-146.
11. Brun R., et al. Human African trypanosomiasis. Lancet 2010, 375:148-159.
12. Yorke W. Trypanosomiasis. Postgrad. Med. J. 1938, 14:358-366.
13. Woo P.T. The haematocrit centrifuge technique for the diagnosis of African trypanosomiasis. Acta Trop. 1970, 27:384-386.
14. Murray M., et al. Improved parasitological technique for diagnosis of African trypanosomiasis. Trans. R. Soc. Trop. Med. Hyg. 1977, 7:325-326.
15. Bailey J.W., Smith D.H. The use of the acridine orange QBC technique in the diagnosis of African trypanosomiasis. Trans. R. Soc. Trop. Med. Hyg. 1992, 86:630.
16. Lumsden W.H., et al. Trypanosoma brucei: miniature anion-exchange centrifugation technique for detection of low parasitaemias: adaptation for field use. Trans. R. Soc. Trop. Med. Hyg. 1979, 73:312-317.
17. Miezan T.W., et al. Evaluation of the parasitologic technics used in the diagnosis of human Trypanosoma gambiense trypanosomiasis in the Ivory Coast. Bull. Soc. Pathol. Exot. 1994, 87:101-104.
18. Büscher P., et al. Improved models of Mini Anion Exchange Centrifugation Technique (mAECT) and Modified Single Centrifugation (MSC) for sleeping sickness diagnosis and staging. PLoS Negl. Trop. Dis. 2009, 3:e471.
19. Aerts D., et al. A kit for in vitro isolation of trypanosomes in the field: first trial with sleeping sickness patients in the Congo Republic. Trans. R. Soc. Trop. Med. Hyg. 1992, 86:394-395.
20. Magnus E., et al. Card-agglutination test with stained trypanosomes (CATT) for serological diagnosis of T. b. gambiense trypanosomiasis. Ann. Soc. Belg. Med. Trop. 1978, 58:169-176.
21. Lejon V., et al. A CATT negative result after treatment for human African trypanosomiasis is no indication for cure. PLoS Negl. Trop. Dis. 2010, 4:e590.
22. Paquet C., et al. Persistence of antibodies to T brucei gambiense after treatment of human trypanosomiasis in Uganda. Lancet 1992, 340:250-1250.
23. Dukes P., et al. Absence of the LiTat 1.3 (CATT antigen) gene in Trypanosoma brucei gambiense stocks from Cameroon. Acta Trop. 1992, 51:123-134.
24. Kanmogne G.D., et al. Detection of Trypanosoma brucei gambiense, in serologically positive but aparasitaemic sleeping-sickness suspects in Cameroon, by PCR. Ann. Trop. Med. Parasit. 1996, 90:475-483.
25. Enyaru J.C.K., et al. Parasitological detection of Trypanosoma brucei gambiense in serologically negative sleeping-sickness suspects from north-western Uganda. Ann. Trop. Med. Parasit. 1998, 92:845-850.
26. Pansaerts R., et al. Increased sensitivity of the card agglutination test CATT/Trypanosoma brucei gambiense by inhibition of complement. Acta Trop. 1998, 70:349-354.
27. Magnus E., et al. Evaluation of an EDTA version of CATT/Trypanosoma brucei gambiense for serological screening of human blood samples. Acta Trop. 2002, 81:7-12.
28. Dukes P., et al. A field comparison of seven diagnostic techniques for human trypanosomiasis in the Luangwa Valley, Zambia. Tropenmed. Parasitol. 1984, 35:141-147.
29. Truc P., et al. A comparison of parasitological methods for the diagnosis of gambian trypanosomiasis in an area of low endemicity in Cote d'Ivoire. Trans. R. Soc. Trop. Med. Hyg. 1994, 88:419-421.
30. Garcia A., et al. Follow-up of card agglutination trypanosomiasis test (CATT) positive but apparently aparasitaemic individuals in Cote d'Ivoire: evidence for a complex and heterogeneous population. Trop. Med. Int. Health 2000, 5:786-793.
31. Koffi M., et al. Aparasitemic serological suspects in Trypanosoma brucei gambiense human African trypanosomiasis: a potential human reservoir of parasites?. Acta Trop. 2006, 98:183-188.
32. Wastling S.L., et al. Latent T. b. gambiense foci - a silent epidemic?. Parasitology 2011, 10.1017/S0031182011000230.
33. Miezan T., et al. Evaluation of Testryp CATT applied to blood samples on filter paper and on diluted blood in a focus of trypanosomiasis due to Trypanosoma brucei gambiense in the Ivory Coast. Bull. World Health Organ. 1991, 69:603-606.
34. Chappuis F., et al. Field evaluation of the CATT/Trypanosoma brucei gambiense on blood-impregnated filter papers for diagnosis of human African trypanosomiasis in southern Sudan. Trop. Med. Int. Health 2002, 7:942-948.
35. Hasker E., et al. A new format of the CATT test for the detection of Human African Trypanosomiasis, designed for use in peripheral health facilities. Trop. Med. Int. Health 2010, 15:263-267.
36. Buscher P., et al. Improved latex agglutination test for detection of antibodies in serum and cerebrospinal fluid of Trypanosoma brucei gambiense infected patients. Acta Trop. 1999, 73:11-20.
37. Weisser N.E., Hall J.C. Applications of single-chain variable fragment antibodies in therapeutics and diagnostics. Biotechnol. Adv. 2009, 27:502-520.
38. WHO Recommendations of the Informal Consultation on Issues for Clinical Product Development for Human African Trypanosomiasis 2007, World Health Organization.
39. Laveran A., Mesnil F. Trypanosomiase humaine ou maladie du sommeil. Trypanosomes et Trypanosomiases 1912, Masson et Cie, Librairies de l'Académie de Medécine, pp. 673-795. 2nd edn.
40. Cattand P., et al. Human African trypanosomiasis: use of double of cerebrospinal fluid to detect trypanosomes. Bull. WHO 1988, 66:83-86.
41. Miézan T., et al. Single centrifugation of cerebrospinal fluid in a sealed Pasteur pipette for simple rapid and sensitive detection of trypanosomes. Trans. R. Soc. Trop. Med. Hyg. 2000, 94:293.
42. Moser D.R., et al. Detection of Trypanosoma congolense and Trypanosoma brucei subspecies by DNA amplification using the polymerase chain reaction. Parasitology 1989, 99:57-66.
43. Xong H.V., et al. A VSG expression site-associated gene confers resistance to human serum in Trypanosoma rhodesiense. Cell 1998, 95:839-846.
44. Welburn S.C., et al. Identification of human infective trypanosomes in animal reservoir of sleeping sickness in Uganda by means of serum-resistance-associated (SRA) gene. Lancet 2001, 358:2017-2019.
45. Picozzi K., et al. A multiplex PCR that discriminates between Trypanosoma brucei brucei and zoonotic T. b. rhodesiense. Exp. Parasitol. 2008, 118:41-46.
46. Degreef C., Hamers R. The serum resistance-associated (Sra) gene of Trypanosoma brucei rhodesiense encodes a variant surface glycoprotein-like protein. Mol. Biochem. Parasitol. 1994, 68:277-284.
47. Campillo N., Carrington M. The origin of the serum resistance associated (SRA) gene and a model of the structure of the SRA polypeptide from Trypanosoma brucei rhodesiense. Mol. Biochem. Parasitol. 2003, 127:79-84.
48. Rdwanska M., et al. Novel primer sequences for polymerase chain reaction-based detection of Trypanosoma brucei gambiense. Am. J. Trop. Med. Hyg. 2002, 6:289-295.
49. Cox A., et al. Constraints to estimating the prevalence of trypanosome infections in East African Zebu cattle. Parasit. Vector 2010, 3:82.
50. Guatelli J.C., et al. Isothermal, in vitro amplification of nucleic acids by a multienzyme reaction modelled after retroviral replication. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:1874-1878.
51. Chan A.B., Fox J.D. NASBA and other transcription-based amplification methods for research and diagnostic microbiology. Rev. Med. Microbiol. 1999, 10:185-196.
52. Compton J. Nucleic acid sequence-based amplification. Nature 1991, 350:91-92.
53. Walker G.T., et al. Strand displacement amplification - an isothermal, in vitro DNA amplification technique. Nucleic Acids Res. 1992, 20:1691-1696.
54. Fire A., Xu S.Q. Rolling replication of short DNA circles. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:4641-4645.
55. Wastling S.L., et al. LAMP for human African trypanosomiasis: a comparative study of detection formats. PLoS Negl. Trop. Dis. 2010, 4:e865.
56. Lizardi P.M., et al. Mutation detection and single-molecule counting using isothermal rolling-circle amplification. Nat. Genet. 1998, 19:225-232.
57. Zhang D.Y., et al. Detection of rare DNA targets by isothermal ramification amplification. Gene 2001, 274:209-216.
58. Van Ness J., et al. Isothermal reactions for the amplification of oligonucleotides. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:4504-4509.
59. Vincent M., et al. Helicase-dependent isothermal DNA amplification. EMBO Rep. 2004, 5:795-800.
60. Kuboki N., et al. Loop-mediated isothermal amplification for detection of African trypanosomes. J. Clin. Microbiol. 2003, 41:5517-5524.
61. Schlaeppi K., et al. The major component of the paraflagellar rod of Trypanosoma brucei is a helical protein that is encoded by two identical, tandemly linked genes. J. Cell Biol. 1989, 109:1695-1709.
62. Berriman M., et al. The genome of the African trypanosome Trypanosoma brucei. Science 2005, 309:416-422.
63. Thekisoe O.M.M., et al. Species-specific loop-mediated isothermal amplification (LAMP) for diagnosis of trypanosomosis. Acta Trop. 2007, 102:182-189.
64. Njiru Z.K., et al. African trypanosomiasis: sensitive and rapid detection of the sub-genus Trypanozoon by loop-mediated isothermal amplification (LAMP) of parasite DNA. Int. J. Parasitol. 2008, 38:589-599.
65. Njiru Z.K., et al. Loop-mediated isothermal amplification (LAMP) method for rapid detection of Trypanosoma brucei rhodesiense. PLoS Negl. Trop. Dis. 2008, 2:e147.
66. Tilley A., et al. Trypanosoma brucei: trypanosome strain typing using PCR analysis of mobile genetic elements (MGE-PCR). Exp. Parasitol. 2003, 104:26-32.
67. Simo G., et al. Trypanosoma brucei s.l.: characterisation of stocks from central Africa by PCR analysis of mobile genetic elements. Exp. Parasitol. 2005, 110:353-362.
68. Matovu E., et al. Comparative detection of trypanosomal DNA by loop-mediated isothermal amplification and PCR from flinders technology associates cards spotted with patient blood. J. Clin. Microbiol. 2010, 48:2087-2090.
69. Mugasa C.M., et al. Detection of Trypanosoma brucei parasites in blood samples using real-time nucleic acid sequence-based amplification. Diagn. Micr. Infec. Dis. 2008, 61:440-445.
70. Mugasa C.M., et al. Nucleic acid sequence-based amplification with oligochromatography for detection of Trypanosoma brucei in clinical samples. J. Clin. Microbiol. 2009, 47:630-635.
71. Matovu E., et al. Phase II evaluation of sensitivity and specificity of PCR and NASBA followed by oligochromatography for diagnosis of human African trypanosomiasis in clinical samples from D.R. Congo and Uganda. PLoS Negl. Trop. Dis. 2010, 4:e737.
72. Ndung'u J.M., et al. 'Piggy-backing' on diagnostic platforms brings hope to neglected diseases: the case of sleeping sickness. PLoS Negl. Trop. Dis. 2010, 4:e715.
73. Boehme C.C., et al. Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries. J. Clin. Microbiol. 2007, 45:1936-1940.
74. Notomi T., et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000, 28:e63.
75. Muyldermans S., et al. Camelid immunoglobulins and nanobody technology. Vet. Immunol. Immunopathol. 2009, 128:178-183.
76. Stijlemans B., et al. Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm. J. Biol. Chem. 2004, 279:1256-1261.
77. Saerens D., et al. Parallel selection of multiple anti-infectome Nanobodies without access to purified antigens. J. Immunol. Methods 2008, 329:138-150.
78. Magez S., Radwanska M. African trypanosomiasis and antibodies: implications for vaccination, therapy and diagnosis. Future Microbiol. 2009, 4:1075-1087.
79. Hainard A., et al. A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients. PLoS Negl. Trop. Dis. 2009, 3:e459.
80. WHO Neglected Tropical Diseases, Hidden Successes, Emerging Opportunities 2009, World Health Organization.
81. Deborggraeve S., et al. Molecular dipstick test for diagnosis of sleeping sickness. J. Clin. Microbiol. 2006, 44:2884-2889.
82. Deborggraeve S., Büscher P. Molecular diagnostics for sleeping sickness: what is the benefit for the patient?. Lancet Infect. Dis. 2010, 10:433-439.
83. Mori Y., et al. Sequence specific visual detection of LAMP reactions by addition of cationic polymers. BMC Biotechnol. 2006, 6:3.
84. Mori Y., et al. Real-time turbidimetry of LAMP reaction for quantifying template DNA. J. Biochem. Biophys. Methods 2004, 59:145-157.
85. Tomita N., et al. Loop-mediated isothermal amplification (LAMP) of gene sequences and simple visual detection of products. Nat. Protoc. 2008, 3:877-882.
86. Goto M., et al. Colorimetric detection of loop-mediated isothermal amplification reaction by using hydroxy napthol blue. Biotechniques 2008, 46:167-172.
87. Lee S.-Y., et al. Compact optical device for isothermal nucleic acids amplification. Sens Actators B: Chem. 2008, 133:493-501.
88. Hataoka Y., et al. Analysis of specific gene by integration of isothermal amplification and electrophoresis on poly(methyl methacrylate) microchips. Anal. Chem. 2004, 76:3689-3693.
89. Njiru Z.K., et al. Loop-mediated isothermal amplification (LAMP) test for detection of Trypanosoma evansi strain B. Exp. Parasitol. 2010, 125:196-201.
90. Rutjes A.W., et al. Evaluation of diagnostic tests when there is no gold standard. A review of methods. Health Technol. Assess. 2007, 11:39-51.
91. Espeland M.A., Handelman S.L. Using latent class models to characterize and assess relative error in discrete measurements. Biometrics 1989, 45:587-599.
92. Hui S.L., Zhou X.H. Evaluation of diagnostic tests without gold standards. Stat. Methods Med. Res. 1998, 7:354-370.
93. Enoe C., et al. Estimation of sensitivity and specificity of diagnostic tests and disease prevalence when the true disease state is unknown. Prev. Vet. Med. 2000, 45:61-81.
94. Branscum A.J., et al. Estimation of diagnostic-test sensitivity and specificity through Bayesian modeling. Prev. Vet. Med. 2005, 68:145-163.
95. Toft N., et al. Diagnosing diagnostic tests: evaluating the assumptions underlying the estimation of sensitivity and specificity in the absence of a gold standard. Prev. Vet. Med. 2005, 68:19-33.
96. Bronsvoort B.M.d., et al. No gold standard estimation of the sensitivity and specificity of two molecular diagnostic protocols for Trypanosoma brucei spp. in Western Kenya. PLoS ONE 2010, 5:e8628.
97. Checchi F., et al. The natural progression of Gambiense sleeping sickness: what is the evidence?. PLoS Negl. Trop. Dis. 2008, 2:e303.
98. Picozzi K., et al. Sleeping sickness in Uganda: a thin line between two fatal diseases. BMJ 2005, 331:1238-1241.
99. Molyneux D., et al. Controlling sleeping sickness: 'when will they ever learn?'. PLoS Negl. Trop. Dis. 2010, 4:e609.